StockWatch
·

TRANSGENE BIOTEK LTD. Q4 FY25 Results

TRABIQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue0.080.7%
Total Income0.120.3%
Expenditure0.83298.8%
PBT-0.71701.2%
Net Profit-0.71701.2%
OPM
NPM
EPS0.091000.0%
View full financials

Informational and educational content only. Not investment advice.